Selected Presentations

- more recent presentations may be available upon request

2021-01-01

Safety and Immunogenicity of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) ICAAC/IDSA Meeting, Washington, DC

2021-01-01

Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus

2021-01-01

Evaluation of Cellular Immune Responses Induced in Mice by Alphavirus Replicon Particle Vaccines for SARS-CoV The American Association of Immunologists Meeting, Miami, FL

2021-01-01

The Effect of Different Glycoprotein Coats on Alphavirus-Replicon Particle Immunogenicity Positive Strand RNA Viruses Meeting, Washington, DC

2021-01-01

Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins

AlphaVax Press Releases - selected

Alphavax Fact Sheet

Access to this document is available by emailing finance@alphavax.com.